ClinicalTrials.gg
Sign In

Glucagonoma clinical trials

The registry lists 33 studies for Glucagonoma across more than 10 countries. 0 are recruiting or about to start. 2 of them are mainly about Glucagonoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-29.

Status

Completed
20
Terminated
8
Withdrawn
3
Status unknown
1
Active, not recruiting
1

Phase

Phase 2
20
Phase 1
9
Phase 3
2

Where

United States
26
United Kingdom
2
Denmark
1
Canada
1
Netherlands
1
Greece
1

Who runs them

National Cancer Institute (NCI) (8) · Memorial Sloan Kettering Cancer Center (2) · Yale University (2) · Eastern Cooperative Oncology Group (2) · Vanderbilt-Ingram Cancer Center (2) · ECOG-ACRIN Cancer Research Group (2) · Federation Francophone de Cancerologie Digestive (1) · Masonic Cancer Center, University of Minnesota (1)

What is being tested here

Drugs under test in Glucagonoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Temozolomide003
Everolimus003
Capecitabine003
Vatalanib002
Bevacizumab012
Octreotide002
Motesanib diphosphate001
Regorafenib001
Pazopanib001
Cixutumumab001

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 8 · Antimetabolites 5 · Alkylating agents 4

Who these studies take

No Glucagonoma study is recruiting now.

Across all 33 studies, recruiting or not: 0% stop at 75 or younger and 0% at 65; 6% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 33 of 33. search them.